At the moment, the pandemic is the major factor affecting penny stocks and blue chips. Covid-19 new variant cases have started appearing around the world, causing people to fear that the pandemic has not yet ended.
As a result of these fears, there has been an increase in volatility and a higher level of uncertainty. Recent weeks have seen the blue-chip stock market flat, but several stocks under $1 have performed well. It is relatively easy to find decent gains on an intraday basis since penny stocks don’t adhere to the rules.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Due to their volatile trade trend, penny stocks are often considered speculative investments. The purpose of purchasing penny stocks is to capitalize on a potential change in stock market trends.
The unpredictable nature of penny stocks makes investing in them always risky. So, understanding penny stock volatility is important for avoiding unpleasant situations.
Investors make informed decisions based on research into relevant investments. Investing in penny stocks can be as profitable as making investments in Fortune 500 companies by knowing their metrics, fundamentals, and developments.
Oragenics Inc. (OGEN) started the day trading at $0.68 and recorded an intraday high of $0.70. It also recorded an intraday low of $0.68 during Friday’s trading session. Oragenics Inc. is a very active stock that recorded a trading volume that is more than 73.82% of the average daily trading volume on Friday. The stock’s trading volume on Friday was 1.62 million, which is more than 73.82% of the total average daily trading volume of 1.62 million.
Hernandez Joseph, 10% Owner, of Oragenics Inc. (OGEN), sold 870,854 shares of Oragenics Inc. stock in an exchange that took place on Jan 14. The shares were sold at an average price of 0.98 each, amounting to a total Sale worth $856,485. As of the close of the sale, 10% Owner now directly holds 0 shares of the organization’s stock, which is now worth about $0.0. The deal was disclosed in a Securities & Exchange Commission legal filing, which can be publicly viewed on the SEC website.
Advaxis Inc. (NASDAQ: ADXS) started the day on 08/27/21, with a price decrease of -1.71% at $0.46. During the day, the stock rose to $0.48 and sunk to $0.435 before settling in for the price of $0.4608 at the close. Taking a more long-term approach, ADXS posted a 52-week range of $0.26-$1.57.
Looking at the revenue path, we saw last quarter’s top-line number come in at 1.38 billion in total revenues, which represents a sequential quarterly sales growth of 366.70%.
Synthetic Biologics Inc. (AMEX: SYN) is currently trading at around $0.49, a price level that means its value has jumped 86.17% higher than its 52-week low. In intraday trading, syn shares have hit a high of $0.50 and a low of $0.47. The last 52 weeks have seen the company’s shares touched a high of $1.70 and a low of $0.26, while the recent trading session has witnessed an intraday change of just 1.25%.
According to WSJ, Synthetic Biologics Inc. (AMEX: SYN) obtained an estimated Buy proposal from the 1 brokerage firm currently keeping a deep eye on the stock performance as compares to its rivals. 0 equity research analysts rated the shares with a selling strategy, 0 gave a hold approach, 1 gave a purchase tip, 0 gave the firm overweight advice, and 0 put the stock under the underweight category. The average price goal of one year between several banks and credit unions that last year discussed the stock is $2.50.